k.fontaine
Submits third-party assay reports on material purchased directly. Based in Angers.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.39%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041992 | Retatrutide | AMB | AMB-2606-N5977 | VendorInvestigate | 2026-Q3 | 98.17 | 3.77 | 96.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020554 | Retatrutide | SSA | SSA-2510-E6613 | Janoshik | 2025-Q4 | 97.12 | 3.97 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020504 | CJC-1295 with DAC | KP | KP-2506-L6194 | Nordanalyt | 2025-Q3 | 99.52 | 4.93 | 89.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020585 | Semaglutide | SSA | SSA-2508-Y7005 | Nordanalyt | 2025-Q3 | 98.61 | 5.18 | 99.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020631 | Semaglutide | GL Biochem | GLBI-2502-B7974 | Janoshik | 2025-Q3 | 97.31 | 5.51 | — | Laboratory-retained | 0 | PASS |
| AX-2025-020088 | Tirzepatide | SWB | SWB-2505-R8575 | Nordanalyt | 2025-Q2 | 98.89 | 2.68 | 106.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018807 | Exenatide | FGP | FGP-2504-V8032 | Janoshik | 2025-Q2 | 98.88 | 4.58 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005035 | Selank | KP | KP-2405-H5953 | Janoshik | 2024-Q3 | 97.62 | 7.83 | — | Buyer-sourced | 0 | FAIL |